12 ha | 18Â h | 24Â h | 36Â h | 48Â h | |||||
---|---|---|---|---|---|---|---|---|---|
Name | No. | Name | No. | Name | No. | Name | No. | Name | No. |
Metabolic pathways | 107 | Metabolic pathways | 107 | Metabolic pathways | 48 | Metabolic pathways | 67 | Metabolic pathways | 60 |
MAPK signaling pathway | 27 | MAPK signaling pathway | 32 | Endocytosis | 16 | MAPK signaling pathway | 26 | MAPK signaling pathway | 21 |
Regulation of actin cytoskeleton | 24 | Regulation of actin cytoskeleton | 22 | Regulation of actin cytoskeleton | 15 | Endocytosis | 21 | Focal adhesion | 17 |
Neuroactive ligand- receptor interaction | 19 | Focal adhesion | 21 | Focal adhesion | 14 | Regulation of actin cytoskeleton | 19 | Endocytosis | 17 |
Focal adhesion | 19 | Endocytosis | 20 | Tight junction | 13 | Focal adhesion | 18 | Tight junction | 15 |
Endocytosis | 19 | Cytokine-cytokine receptor interaction | 18 | Neuroactive ligand- receptor interaction | 13 | Cytokine-cytokine receptor interaction | 18 | Regulation of actin cytoskeleton | 15 |
Cytokine- cytokine receptor interaction | 18 | Neuroactive ligand-receptor interaction | 17 | MAPK signaling pathway | 12 | Tight junction | 15 | Ubiquitin mediated proteolysis | 14 |
Tight junction | 17 | Purine metabolism | 16 | Vascular smooth muscle contraction | 11 | Neuroactive ligand- receptor interaction | 14 | Neuroactive ligand- receptor interaction | 13 |
VEGF signaling pathway | 14 | Vascular smooth muscle contraction | 15 | Calcium signaling pathway | 10 | Calcium signaling pathway | 13 | Calcium signaling pathway | 13 |
RNA degradation | 14 | Lysosome | 15 | Ubiquitin mediated proteolysis | 9 | Vascular smooth muscle contraction | 12 | Vascular smooth muscle contraction | 11 |
Cell adhesion molecules (CAMs) | 14 | Tight junction | 14 | Lysosome | 9 | Jak-STAT signaling pathway | 12 | Cell adhesion molecules (CAMs) | 11 |